Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson's disease

Cited by (290)

Items 101–200 of 290

1. Probiotic Clostridium butyricum ameliorated motor deficits in a mouse model of Parkinson’s disease via gut microbiota-GLP-1 pathway
   Sun, Jing, Li, Haijun, Jin, Yangjie, Yu, Jiaheng, Mao, Shiyin, Su, Kuan-Pin, Ling, Zongxin, Liu, Jiaming · 2021 · Brain, Behavior, and Immunity
2. Gut microbiota in patients with Parkinson's disease in southern China
   Lin, Aiqun, Zheng, Wenxia, He, Yan, Tang, Wenli, Wei, Xiaobo, He, Rongni, Huang, Wei, Su, Yuying, Huang, Yaowei, Zhou, Hongwei et al. · 2018 · Parkinsonism & Related Disorders
3. Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease
   Chen, Szu-Ju, Chen, Chieh-Chang, Liao, Hsin-Yu, Lin, Ya-Ting, Wu, Yu-Wei, Liou, Jyh-Ming, Wu, Ming-Shiang, Kuo, Ching-Hua, Lin, Chin-Hsien · 2022 · Neurology
4. ApoE isoform– and microbiota-dependent progression of neurodegeneration in a mouse model of tauopathy
   Seo, Dong-oh, O’Donnell, David, Jain, Nimansha, Ulrich, Jason D., Herz, Jasmin, Li, Yuhao, Lemieux, Mackenzie, Cheng, Jiye, Hu, Hao, Serrano, Javier R. et al. · 2023 · Science
5. Gut microbiota changes in the extreme decades of human life: a focus on centenarians
   Santoro, Aurelia, Ostan, Rita, Candela, Marco, Biagi, Elena, Brigidi, Patrizia, Capri, Miriam, Franceschi, Claudio · 2018 · Cellular and Molecular Life Sciences
6. Characterizing Dysbiosis of Gut Microbiome in PD: Evidence for Overabundance of Opportunistic Pathogens
   Wallen, Zachary D., Appah, Mary, Dean, Marissa N., Sesler, Cheryl L., Factor, Stewart A., Molho, Eric, Zabetian, Cyrus P., Standaert, David G., Payami, Haydeh · 2020 · npj Parkinson s Disease
7. Progression of Parkinson's disease is associated with gut dysbiosis: Two-year follow-up study
   Minato, Tomomi, Maeda, Tetsuya, Fujisawa, Yoshiro, Tsuji, Hirokazu, Nomoto, Koji, Ohno, Kinji, Hirayama, Masaaki · 2017 · PLOS ONE
8. Gut microbiota-derived propionate mediates the neuroprotective effect of osteocalcin in a mouse model of Parkinson’s disease
   Hou, Yan-fang, Shan, Chang, Zhuang, Si-yue, Zhuang, Qian-qian, Ghosh, Arijit, Zhu, Ke-cheng, Kong, Xiao-ke, Wang, Shu-min, Gong, Yan-ling, Yang, Yu-ying et al. · 2021 · Microbiome
9. A new perspective on lipid research in age-related macular degeneration
   van Leeuwen, Elisabeth M., Emri, Eszter, Merle, Benedicte M.J., Colijn, Johanna M., Kersten, Eveline, Cougnard-Gregoire, Audrey, Dammeier, Sascha, Meester-Smoor, Magda, Pool, Frances M., de Jong, Eiko K. et al. · 2018 · Progress in Retinal and Eye Research
10. α-Synuclein in gut endocrine cells and its implications for Parkinson’s disease
    Chandra, Rashmi, Hiniker, Annie, Kuo, Yien-Ming, Nussbaum, Robert L., Liddle, Rodger A. · 2017 · JCI Insight
11. Gut inflammation and dysbiosis in human motor neuron disease
    Rowin, Julie, Xia, Yinglin, Jung, Barbara, Sun, Jun · 2017 · Physiological Reports
12. The Microbiome as a Modifier of Neurodegenerative Disease Risk
    Fang, P., Kazmi, S.A., Jameson, K.G., Hsiao, E.Y. · 2020 · Cell Host & Microbe
13. Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson’s disease
    Fan, Zheng, Pan, Yu-Ting, Zhang, Zhi-Yuan, Yang, Hui, Yu, Shu-Yue, Zheng, Yan, Ma, Jing-Hong, Wang, Xiao-Min · 2020 · Journal of Neuroinflammation
14. The function of gut microbiota in immune-related neurological disorders: a review
    Sittipo, Panida, Choi, Jaeyoon, Lee, Soojin, Lee, Yun Kyung · 2022 · Journal of Neuroinflammation
15. The Association Between the Gut Microbiota and Parkinson’s Disease, a Meta-Analysis
    Shen, Ting, Yue, Yumei, He, Tingting, Huang, Cong, Qu, Boyi, Lv, Wen, Lai, Hsin-Yi · 2021 · Frontiers in Aging Neuroscience
16. Dysbiosis of gut microbiota in a selected population of Parkinson's patients
    Pietrucci, Daniele, Cerroni, Rocco, Unida, Valeria, Farcomeni, Alessio, Pierantozzi, Mariangela, Mercuri, Nicola Biagio, Biocca, Silvia, Stefani, Alessandro, Desideri, Alessandro · 2019 · Parkinsonism & Related Disorders
17. Microbiome profiling reveals gut dysbiosis in a transgenic mouse model of Huntington's disease
    Kong, Geraldine, Cao, Kim-Anh Lê, Judd, Louise M., Li, ShanShan, Renoir, Thibault, Hannan, Anthony J. · 2020 · Neurobiology of Disease
18. Peripheral immune system in aging and Alzheimer’s disease
    Cao, Wei, Zheng, Hui · 2018 · Molecular Neurodegeneration
19. Gut microbiota modulate neurobehavior through changes in brain insulin sensitivity and metabolism
    Soto, Marion, Herzog, Clémence, Pacheco, Julian A., Fujisaka, Shiho, Bullock, Kevin, Clish, Clary B., Kahn, C. Ronald · 2018 · Molecular Psychiatry
20. Neurogenesis and prolongevity signaling in young germ-free mice transplanted with the gut microbiota of old mice
    Kundu, Parag, Lee, Hae Ung, Garcia-Perez, Isabel, Tay, Emmy Xue Yun, Kim, Hyejin, Faylon, Llanto Elma, Martin, Katherine A., Purbojati, Rikky, Drautz-Moses, Daniela I., Ghosh, Sujoy et al. · 2019 · Science Translational Medicine
21. Probiotics mixture increases butyrate, and subsequently rescues the nigral dopaminergic neurons from MPTP and rotenone-induced neurotoxicity
    Srivastav, Sunil, Neupane, Sabita, Bhurtel, Sunil, Katila, Nikita, Maharjan, Sailesh, Choi, Hyukjae, Hong, Jin Tae, Choi, Dong-Young · 2019 · The Journal of Nutritional Biochemistry
22. Probiotic Bacillus subtilis protects against α-synuclein aggregation in C. elegans
    Goya, María Eugenia, Xue, Feng, Sampedro-Torres-Quevedo, Cristina, Arnaouteli, Sofia, Riquelme-Dominguez, Lourdes, Romanowski, Andrés, Brydon, Jack, Ball, Kathryn L., Stanley-Wall, Nicola R., Doitsidou, Maria · 2020 · Cell Reports
23. Gut dysbiosis contributes to amyloid pathology, associated with C/EBPβ/AEP signaling activation in Alzheimer’s disease mouse model
    Chen, Chun, Ahn, Eun Hee, Kang, Seong Su, Liu, Xia, Alam, Ashfaqul, Ye, Keqiang · 2020 · Science Advances
24. The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer’s disease pathology: From antioxidant to epigenetic therapy
    Griñán-Ferré, Christian, Bellver-Sanchis, Aina, Izquierdo, Vanessa, Corpas, Rubén, Roig-Soriano, Joan, Chillón, Miguel, Andres-Lacueva, Cristina, Somogyvári, Milán, Sőti, Csaba, Sanfeliu, Coral et al. · 2021 · Ageing Research Reviews
25. Fecal microbiota transplantation to treat Parkinson's disease with constipation: A case report
    Huang, Hongli, Xu, Haoming, Luo, Qingling, He, Jie, Li, Mengyan, Chen, Huiting, Tang, Wenjuan, Nie, Yuqiang, Zhou, Yongjian · 2019 · Medicine
26. You’ve got male: Sex and the microbiota-gut-brain axis across the lifespan
    Jaggar, Minal, Rea, Kieran, Spichak, Simon, Dinan, Timothy G., Cryan, John F. · 2020 · Frontiers in Neuroendocrinology
27. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle
    Chidambaram, Saravana Babu, Essa, Musthafa Mohamed, Rathipriya, A.G., Bishir, Muhammed, Ray, Bipul, Mahalakshmi, Arehally M., Tousif, A.H., Sakharkar, Meena K., Kashyap, Rajpal Singh, Friedland, Robert P. et al. · 2022 · Pharmacology & Therapeutics
28. Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology
    Manfredsson, Fredric P., Luk, Kelvin C., Benskey, Matthew J., Gezer, Aysegul, Garcia, Joanna, Kuhn, Nathan C., Sandoval, Ivette M., Patterson, Joseph R., O'Mara, Alana, Yonkers, Reid et al. · 2018 · Neurobiology of Disease
29. Gut dysbiosis in Huntington’s disease: associations among gut microbiota, cognitive performance and clinical outcomes
    Wasser, Cory I, Mercieca, Emily-Clare, Kong, Geraldine, Hannan, Anthony J, McKeown, Sonja J, Glikmann-Johnston, Yifat, Stout, Julie C · 2020 · Brain Communications
30. Colon-delivered short-chain fatty acids attenuate the cortisol response to psychosocial stress in healthy men: a randomized, placebo-controlled trial
    Dalile, Boushra, Vervliet, Bram, Bergonzelli, Gabriela, Verbeke, Kristin, Van Oudenhove, Lukas · 2020 · Neuropsychopharmacology
31. Neuroprotection of fasting mimicking diet on MPTP-induced Parkinson's disease mice via gut microbiota and metabolites
    Zhou, Zhi-Lan, Jia, Xue-Bing, Sun, Meng-Fei, Zhu, Ying-Li, Qiao, Chen-Meng, Zhang, Bo-Ping, Zhao, Li-Ping, Yang, Qin, Cui, Chun, Chen, Xue et al. · 2019 · Neurotherapeutics
32. Mediterranean diet adherence is related to reduced probability of prodromal Parkinson's disease
    Maraki, Maria I., Yannakoulia, Mary, Stamelou, Maria, Stefanis, Leonidas, Xiromerisiou, Georgia, Kosmidis, Mary H., Dardiotis, Efthimios, Hadjigeorgiou, Georgios M., Sakka, Paraskevi, Anastasiou, Costas A. et al. · 2019 · Movement Disorders
33. Deciphering the Chemical Lexicon of Host–Gut Microbiota Interactions
    Nicolas, Gael R., Chang, Pamela V. · 2019 · Trends in Pharmacological Sciences
34. Longitudinal Analysis of Fecal Microbiome and Pathologic Processes in a Rotenone Induced Mice Model of Parkinson’s Disease
    Yang, Xiaodong, Qian, Yiwei, Xu, Shaoqing, Song, Yanyan, Xiao, Qin · 2018 · Frontiers in Aging Neuroscience
35. Systemic factors as mediators of brain homeostasis, ageing and neurodegeneration
    Pluvinage, John V., Wyss-Coray, Tony · 2020 · Nature Reviews Neuroscience
36. Outside in: Unraveling the Role of Neuroinflammation in the Progression of Parkinson's Disease
    Troncoso-Escudero, Paulina, Parra, Alejandra, Nassif, Melissa, Vidal, Rene L. · 2018 · Frontiers in Neurology
37. Steroids, stress and the gut microbiome-brain axis
    Tetel, M. J., de Vries, G. J., Melcangi, R. C., Panzica, G., O'Mahony, S. M. · 2018 · Journal of Neuroendocrinology
38. Altered gut microbiome in parkinson’s disease and the influence of lipopolysaccharide in a human α-synuclein over-expressing mouse model
    Gorecki, Anastazja M., Preskey, Leah, Bakeberg, Megan C., Kenna, Jade E., Gildenhuys, Christi, MacDougall, Gabriella, Dunlop, Sarah A., Mastaglia, Frank L., Akkari, P. Anthony, Koengten, Frank et al. · 2019 · Frontiers in Neuroscience
39. Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease
    Zhu, Manlian, Liu, Xia, Ye, Yiru, Yan, Xiumei, Cheng, Yiwen, Zhao, Longyou, Chen, Feng, Ling, Zongxin · 2022 · Frontiers in Immunology
40. Human physiomimetic model integrating microphysiological systems of the gut, liver, and brain for studies of neurodegenerative diseases
    Trapecar, Martin, Wogram, Emile, Svoboda, Devon, Communal, Catherine, Omer, Attya, Lungjangwa, Tenzin, Sphabmixay, Pierre, Velazquez, Jason, Schneider, Kirsten, Wright, Charles W. et al. · 2021 · Science Advances
41. Colony-Stimulating Factor 1 Receptor (CSF1R) Regulates Microglia Density and Distribution, but Not Microglia Differentiation In Vivo
    Oosterhof, Nynke, Kuil, Laura E., van der Linde, Herma C., Burm, Saskia M., Berdowski, Woutje, van Ijcken, Wilfred F.J., van Swieten, John C., Hol, Elly M., Verheijen, Mark H.G., van Ham, Tjakko J. · 2018 · Cell Reports
42. Microbiota-gut brain axis involvement in neuropsychiatric disorders
    Iannone, Luigi Francesco, Preda, Alberto, Blottière, Hervé M., Clarke, Gerard, Albani, Diego, Belcastro, Vincenzo, Carotenuto, Marco, Cattaneo, Annamaria, Citraro, Rita, Ferraris, Cinzia et al. · 2019 · Expert Review of Neurotherapeutics
43. Gut Microbiota Differs Between Parkinson’s Disease Patients and Healthy Controls in Northeast China
    Li, Chunxiao, Cui, Li, Yang, Yimin, Miao, Jing, Zhao, Xiuzhen, Zhang, Jingdian, Cui, Guohong, Zhang, Ying · 2019 · Frontiers in Molecular Neuroscience
44. Evaluation of fecal microbiota transplantation in Parkinson's disease patients with constipation
    Kuai, Xiao-yi, Yao, Xiao-han, Xu, Li-juan, Zhou, Yu-qing, Zhang, Li-ping, Liu, Yi, Pei, Shao-fang, Zhou, Chun-li · 2021 · Microbial Cell Factories
45. Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications?
    Pellegrini, Carolina, Antonioli, Luca, Calderone, Vincenzo, Colucci, Rocchina, Fornai, Matteo, Blandizzi, Corrado · 2020 · Progress in Neurobiology
46. The Gut Microbial Bile Acid Modulation and Its Relevance to Digestive Health and Diseases
    Fogelson, Kelly A., Dorrestein, Pieter C., Zarrinpar, Amir, Knight, Rob · 2023 · Gastroenterology
47. The gut microbiota mediates reward and sensory responses associated with regimen-selective morphine dependence
    Lee, Kevin, Vuong, Helen E., Nusbaum, David J., Hsiao, Elaine Y., Evans, Christopher J., Taylor, Anna M. W. · 2018 · Neuropsychopharmacology
48. Parkinson’s Disease and the Gastrointestinal Microbiome
    Lubomski, Michal, Tan, Ai Huey, Lim, Shen-Yang, Holmes, Andrew J., Davis, Ryan L., Sue, Carolyn M. · 2020 · Journal of Neurology
49. Oral administration of Proteus mirabilis damages dopaminergic neurons and motor functions in mice
    Choi, Jin Gyu, Kim, Namkwon, Ju, In Gyoung, Eo, Hyeyoon, Lim, Su-Min, Jang, Se-Eun, Kim, Dong-Hyun, Oh, Myung Sook · 2018 · Scientific Reports
50. Understanding the Gut–Brain Axis and Its Therapeutic Implications for Neurodegenerative Disorders
    Zheng, Yadong, Bonfili, Laura, Wei, Tao, Eleuteri, Anna Maria · 2023 · Nutrients
51. Systematic Analysis of Gut Microbiome Reveals the Role of Bacterial Folate and Homocysteine Metabolism in Parkinson’s Disease
    Rosario, Dorines, Bidkhori, Gholamreza, Lee, Sunjae, Bedarf, Janis, Hildebrand, Falk, Le Chatelier, Emmanuelle, Uhlen, Mathias, Ehrlich, Stanislav Dusko, Proctor, Gordon, Wüllner, Ullrich et al. · 2021 · Cell Reports
52. The Role of the Gut Microbiota in the Pathogenesis of Parkinson's Disease
    Yang, Dongming, Zhao, Deming, Ali Shah, Syed Zahid, Wu, Wei, Lai, Mengyu, Zhang, Xixi, Li, Jie, Guan, Zhiling, Zhao, Huafen, Li, Wen et al. · 2019 · Frontiers in Neurology
53. Integrated Analyses of Microbiome and Longitudinal Metabolome Data Reveal Microbial-Host Interactions on Sulfur Metabolism in Parkinson’s Disease
    Hertel, Johannes, Harms, Amy C., Heinken, Almut, Baldini, Federico, Thinnes, Cyrille C., Glaab, Enrico, Vasco, Daniel A., Pietzner, Maik, Stewart, Isobel D., Wareham, Nicholas J. et al. · 2019 · Cell Reports
54. Lactobacillus Plantarum PS128 Alleviates Neurodegenerative Progression in 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Mouse Models of Parkinson’s Disease
    Liao, Jian-Fu, Cheng, Yun-Fang, You, Shu-Ting, Kuo, Wen-Chun, Huang, Chi-Wei, Chiou, Jen-Jie, Hsu, Chih-Chieh, Hsieh-Li, Hsiu-Mei, Wang, Sabrina, Tsai, Ying-Chieh · 2020 · Brain, Behavior, and Immunity
55. Parkinson’s Disease and Gut Microbiota
    Hirayama, Masaaki, Ohno, Kinji · 2021 · Annals of Nutrition and Metabolism
56. Time to test antibacterial therapy in Alzheimer’s disease
    Panza, Francesco, Lozupone, Madia, Solfrizzi, Vincenzo, Watling, Mark, Imbimbo, Bruno P · 2019 · Brain
57. Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics
    Peterson, Christine Tara · 2020 · Journal of Evidence-Based Integrative Medicine
58. Sodium butyrate ameliorates the impairment of synaptic plasticity by inhibiting the neuroinflammation in 5XFAD mice
    Jiang, Yu, Li, Kai, Li, Xiaolin, Xu, Lanju, Yang, Zhuo · 2021 · Chemico-Biological Interactions
59. Gut Microbiota Dysbiosis Is Associated with Elevated Bile Acids in Parkinson’s Disease
    Li, Peipei, Killinger, Bryan A., Ensink, Elizabeth, Beddows, Ian, Yilmaz, Ali, Lubben, Noah, Lamp, Jared, Schilthuis, Meghan, Vega, Irving E., Woltjer, Randy et al. · 2021 · Metabolites
60. Altered gut microbiota associated with symptom severity in schizophrenia
    Li, Shijia, Zhuo, Min, Huang, Xia, Huang, Yuanyuan, Zhou, Jing, Xiong, Dongsheng, Li, Jiahui, Liu, Ya, Pan, Zhilin, Li, Hehua et al. · 2020 · PeerJ
61. Efficacy of fecal microbiota transplantation in patients with Parkinson’s disease: clinical trial results from a randomized, placebo-controlled design
    Cheng, Yi, Tan, Guohua, Zhu, Qihui, Wang, Chun, Ruan, Guangcong, Ying, Senhong, Qie, Jinlong, Hu, Xiaofei, Xiao, Zhifeng, Xu, Fenghua et al. · 2023 · Gut Microbes
62. Microbiota–neuroepithelial signalling across the gut–brain axis
    Ohara, Takahiro E., Hsiao, Elaine Y. · 2025 · Nature Reviews Microbiology
63. Toll-like receptors and their therapeutic potential in Parkinson’s disease and α-synucleinopathies
    Kouli, Antonina, Horne, C.B., Williams-Gray, C.H. · 2019 · Brain Behavior and Immunity
64. Probiotics may have beneficial effects in parkinson’s disease: In vitro evidence
    Magistrelli, Luca, Amoruso, Angela, Mogna, Luca, Graziano, Teresa, Cantello, Roberto, Pane, Marco, Comi, Cristoforo · 2019 · Frontiers in Immunology
65. Bile acids: a communication channel in the gut-brain axis
    Monteiro-Cardoso, Vera F., Corlianò, Maria, Singaraja, Roshni R. · 2021 · NeuroMolecular Medicine
66. Diet in Parkinson’s Disease: Critical Role for the Microbiome
    Jackson, Aeja, Forsyth, Christopher B., Shaikh, Maliha, Voigt, Robin M., Engen, Phillip A., Ramirez, Vivian, Keshavarzian, Ali · 2019 · Frontiers in Neurology
67. Inflammatory bowel diseases and Parkinson's disease
    Brudek, Tomasz · 2019 · Journal of Parkinson’s Disease
68. Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson’s Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder
    Nishiwaki, Hiroshi, Hamaguchi, Tomonari, Ito, Mikako, Ishida, Tomohiro, Maeda, Tetsuya, Kashihara, Kenichi, Tsuboi, Yoshio, Ueyama, Jun, Shimamura, Teppei, Mori, Hiroshi et al. · 2020 · mSystems
69. Healthspan Maintenance and Prevention of Parkinson's-like Phenotypes with Hydroxytyrosol and Oleuropein Aglycone in C. elegans
    Brunetti, Giovanni, Di Rosa, Gabriele, Scuto, Maria, Leri, Manuela, Stefani, Massimo, Schmitz-Linneweber, Christian, Calabrese, Vittorio, Saul, Nadine · 2020 · International Journal of Molecular Sciences
70. Fecal Microbiome Transplantation from Children with Autism Spectrum Disorder Modulates Tryptophan and Serotonergic Synapse Metabolism and Induces Altered Behaviors in Germ-Free Mice
    Xiao, Lu, Yan, Junyan, Yang, Ting, Zhu, Jiang, Li, Tingyu, Wei, Hong, Chen, Jie · 2021 · mSystems
71. Gut Metagenomics-Derived Genes as Potential Biomarkers of Parkinson’s Disease
    Qian, Yiwei, Yang, Xiaodong, Xu, Shaoqing, Huang, Pei, Li, Binyin, Du, Juanjuan, He, Yixi, Su, Binghua, Xu, Li-Ming, Wang, Liang et al. · 2020 · Brain
72. Morinda officinalis oligosaccharides increase serotonin in the brain and ameliorate depression via promoting 5-hydroxytryptophan production in the gut microbiota
    Zhang, Zheng-Wei, Gao, Chun-Sheng, Zhang, Heng, Yang, Jian, Wang, Ya-Ping, Pan, Li-Bin, Yu, Hang, He, Chi-Yu, Luo, Hai-Bin, Zhao, Zhen-Xiong et al. · 2022 · Acta Pharmaceutica Sinica B
73. Safety and efficacy of faecal microbiota transplantation in patients with mild to moderate Parkinson's disease (GUT-PARFECT): a double-blind, placebo-controlled, randomised, phase 2 trial
    Bruggeman, Arnout, Vandendriessche, Charysse, Hamerlinck, Hannelore, De Looze, Danny, Tate, David J., Vuylsteke, Marnik, De Commer, Lindsey, Devolder, Lindsay, Raes, Jeroen, Verhasselt, Bruno et al. · 2024 · eClinicalMedicine
74. Brain macrophage development, diversity and dysregulation in health and disease
    Silvin, Aymeric, Qian, Jiawen, Ginhoux, Florent · 2023 · Cellular & Molecular Immunology
75. Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
    Brás, Inês C., Outeiro, Tiago F. · 2021 · Cells
76. Probiotics synergized with conventional regimen in managing Parkinson’s disease
    Sun, Hairong, Zhao, Feiyan, Liu, Yuanyuan, Ma, Teng, Jin, Hao, Quan, Keyu, Leng, Bing, Zhao, Junwu, Yuan, Xiaoling, Li, Zhenguang et al. · 2022 · npj Parkinson's Disease
77. Gut Microbiome and Osteoporosis
    Ding, Kai, Hua, Fei, Ding, Wenge · 2020 · Aging and disease
78. The Link between Gut Dysbiosis and Neuroinflammation in Parkinson’s Disease
    Baizabal-Carvallo, José Fidel, Alonso-Juarez, Marlene · 2020 · Neuroscience
79. Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson’s Disease
    Mulak, Agata, Koszewicz, Magdalena, Panek-Jeziorna, Magdalena, Koziorowska-Gawron, Ewa, Budrewicz, Sławomir · 2019 · Frontiers in Neuroscience
80. Triangulating nutrigenomics, metabolomics and microbiomics toward personalized nutrition and healthy living
    Lagoumintzis, George, Patrinos, George P. · 2023 · Human Genomics
81. Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson’s disease
    Bhattarai, Yogesh, Si, Jie, Pu, Meng, Ross, Owen A., McLean, Pamela J., Till, Lisa, Moor, William, Grover, Madhusudan, Kandimalla, Karunya K., Margolis, Kara G. et al. · 2021 · Gut Microbes
82. Fluoxetine ameliorates dysbiosis in a depression model induced by chronic unpredicted mild stress in mice
    Sun, Lijuan, Zhang, Haohao, Cao, Ying, Wang, Chenchen, Zhao, Changhai, Wang, Huaning, Cui, Guangbin, Wang, Meixia, Pan, Yan, Shi, Yupeng et al. · 2019 · International Journal of Medical Sciences
83. Gastrointestinal dysfunction in Parkinson’s disease: Molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation
    Metta, Vinod, Leta, Valentina, Mrudula, Kandadai Rukmini, Prashanth, L. K., Goyal, Vinay, Borgohain, Rupam, Chung-Faye, Guy, Chaudhuri, K. Ray · 2022 · Journal of Neurology
84. Fecal microbiota transplant as a potential treatment for Parkinson's disease – A case series
    Segal, Arik, Zlotnik, Yair, Moyal-Atias, Keren, Abuhasira, Ran, Ifergane, Gal · 2021 · Clinical Neurology and Neurosurgery
85. The Gut-Brain Axis in Inflammatory Bowel Disease—Current and Future Perspectives
    Günther, Claudia, Rothhammer, Veit, Karow, Marisa, Neurath, Markus, Winner, Beate · 2021 · International Journal of Molecular Sciences
86. Gut microbiome as a clinical tool in gastrointestinal disease management: are we there yet?
    Quigley, Eamonn M. M. · 2017 · Nature Reviews Gastroenterology & Hepatology
87. Different effects of constitutive and induced microbiota modulation on microglia in a mouse model of Alzheimer’s disease
    Mezö, Charlotte, Dokalis, Nikolaos, Mossad, Omar, Staszewski, Ori, Neuber, Jana, Yilmaz, Bahtiyar, Schnepf, Daniel, de Agüero, Mercedes Gomez, Ganal-Vonarburg, Stephanie C., Macpherson, Andrew J. et al. · 2020 · Acta Neuropathologica Communications
88. Interventional Influence of the Intestinal Microbiome Through Dietary Intervention and Bowel Cleansing Might Improve Motor Symptoms in Parkinson’s Disease
    Hegelmaier, Tobias, Lebbing, Marco, Duscha, Alexander, Tomaske, Laura, Tönges, Lars, Holm, Jacob Bak, Bjørn Nielsen, Henrik, Gatermann, Sören G., Przuntek, Horst, Haghikia, Aiden · 2020 · Cells
89. Aging microglia
    Antignano, Ignazio, Liu, Yingxiao, Offermann, Nina, Capasso, Melania · 2023 · Cellular and Molecular Life Sciences
90. Gut microbiota–driven brain Aβ amyloidosis in mice requires microglia
    Dodiya, Hemraj B., Lutz, Holly L., Weigle, Ian Q., Patel, Priyam, Michalkiewicz, Julia, Roman-Santiago, Carlos J., Zhang, Can Martin, Liang, Yingxia, Srinath, Abhinav, Zhang, Xulun et al. · 2022 · Journal of Experimental Medicine
91. Altered Gut Microbiota in Parkinson’s Disease Patients/Healthy Spouses and Its Association with Clinical Features
    Zhang, Fan, Yue, Liya, Fang, Xing, Wang, Gengchao, Li, Cuidan, Sun, Xiaodong, Jia, Xinmiao, Yang, Jingjing, Song, Jinhui, Zhang, Yu et al. · 2020 · Parkinsonism & Related Disorders
92. The gut microbiome modulates the transformation of microglial subtypes
    Huang, Yu, Wu, Jing, Zhang, Hanping, Li, Yifan, Wen, Lu, Tan, Xunmin, Cheng, Ke, Liu, Yiyun, Pu, Juncai, Liu, Lanxiang et al. · 2023 · Molecular Psychiatry
93. Can we ‘seize’ the gut microbiota to treat epilepsy?
    De Caro, Carmen, Iannone, Luigi Francesco, Citraro, Rita, Striano, Pasquale, De Sarro, Giovambattista, Constanti, Andrew, Cryan, John F., Russo, Emilio · 2019 · Neuroscience & Biobehavioral Reviews
94. The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression : Towards Characterization of the “MS Microbiome.”
    Pröbstel, Anne-Katrin, Baranzini, Sergio E. · 2018 · Neurotherapeutics
95. Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson's disease
    Hou, Yichao, Li, Xingqi, Liu, Chang, Zhang, Ming, Zhang, Xiaoying, Ge, Shaoyang, Zhao, Liang · 2021 · Experimental Gerontology
96. TLR2 and TLR4 in Parkinson’s disease pathogenesis: The environment takes a toll on the gut
    Gorecki, Anastazja M., Anyaegbu, Chidozie C., Anderton, Ryan S. · 2021 · Translational Neurodegeneration
97. Enduring behavioral effects induced by birth by caesarean section in the mouse
    Morais, Livia H., Golubeva, Anna V., Moloney, Gerard M., Moya-Pérez, Angela, Ventura-Silva, Ana Paula, Arboleya, Silvia, Bastiaanssen, Thomaz F.S., O’Sullivan, Orla, Rea, Kieran, Borre, Yuliya et al. · 2020 · Current Biology
98. Gut bacterial composition in a mouse model of Parkinson’s disease
    Perez-Pardo, P., Dodiya, H.B., Engen, P.A., Naqib, A., Forsyth, C.B., Green, S.J., Garssen, J., Keshavarzian, A., Kraneveld, A.D. · 2018 · Beneficial Microbes
99. Potential roles of gut microbiota and microbial metabolites in Parkinson’s disease
    Zheng, Shen-Yuan, Li, Hai-Xia, Xu, Rui-Chen, Miao, Wen-Teng, Dai, Ming-Yuan, Ding, Song-Tao, Liu, Han-Deng · 2021 · Ageing Research Reviews
100. The microbiota–microglia axis in central nervous system disorders
     Mossad, Omar, Erny, Daniel · 2020 · Brain Pathology